Private Equity
Location
Rotterdam, The Netherlands
Boston, MA, USA
Private Equity
All Portfolio items
See full Private Equity portfolio
Viroclinics Biosciences is a leader in diagnostic and clinical-trial services. It is one of the few labs in the world able to perform highly complex, specialized diagnostic and preclinical studies in the field of virology. Viroclinics operates globally as the preferred virology testing laboratory for top-ten biopharmaceutical companies.
Gilde acquired a majority share in 2013. During Gilde ownership Viroclinics developed new services for the biopharmaceutical industry, expanded its facilities and tripled its revenues. Viroclinics was sold in 2017 to Parcom Capital.
More Viroclinics Biosciences news
d3 Medicine LLC and Viroclinics Biosciences BV form virology drug development alliance to serve the
Gilde Healthcare Services acquires majority share in Viroclinics Biosciences from Erasmus MC
Private Equity
NIZO
NIZO is a state-of-the art, globally operating contract research organization for better food and health outcomes with headquarters in Ede, the Netherlands. It focuses on the development and application of innovative technologies for its customers in the global food industry
Private Equity
Symeres
Symeres, previously known as Mercachem and Syncom, is a leading mid-sized European contract research organization (CRO) for integrated outsourced drug discovery services. Symeres focuses on serving smaller and midsized players with the quality and professional standards of larger CROs, enabling
Private Equity
Tandarts Today
Tandarts Today is a fast-growing chain of dental practices and dental laboratories based in Eindhoven, the Netherlands. The chain aims to make a positive impact on dental care by addressing three key challenges: promoting oral health, enhancing the accessibility of
